AcoArt sICAS: DCB in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Intracranial Drug-coated Balloon Catheters in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
Sponsor: Acotec Scientific Co., Ltd
This NA trial investigates Intracranial Atherosclerosis and Stroke and is currently completed. Acotec Scientific Co., Ltd leads this study, which shows 12 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2023 — Jul 2024 [monthly]
Completed NA
-
Jul 2023 — Nov 2023 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2023 — Jul 2023 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Sep 2022 — Jun 2023 [monthly]
Recruiting NA
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Apr 2021 — Jun 2021 [monthly]
Not Yet Recruiting NA
-
Feb 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Acotec Scientific Co., Ltd
- Beijing Tiantan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .